Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Slikker

Showing results (11-20 of 138) with videos related to

Pageof 14
Sort By:
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 22, 2005
Role of the standard deviation in the estimation of benchmark doses with continuous dataDavid W Gaylor, William Slikker
Toxicology and Applied Pharmacology|June 22, 2005
Biomarkers of adult and developmental neurotoxicityWilliam Slikker, John F Bowyer
Reproductive Toxicology (Elmsford, N.Y.)|February 3, 2005
Application of a systems biology approach to developmental neurotoxicologyWilliam Slikker, Zengjun Xu, Cheng Wang
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 26, 2004
N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adultsWilliam Slikker, Nan Mei, Tao Chen
Annals of the New York Academy of Sciences|September 24, 2005
Systems biology/systems toxicology: application to developmental neurotoxicology/neuroprotectionWilliam Slikker, Zengjun Xu, Cheng Wang
Journal of the American Association for Laboratory Animal Science : JAALAS|November 13, 2007
Effect of prolonged ketamine exposure on cardiovascular physiology in pregnant and infant rhesus monkeys (Macaca mulatta)Charlotte E Hotchkiss, Cheng Wang, William Slikker
Experimental Biology and Medicine (Maywood, N.J.)|June 16, 2023
Preface: 2022 International Conference on Neuroprotective AgentsWilliam Slikker, Tucker A Patterson, Russell J Andrews
Environmental Health Perspectives|February 3, 2004
Incorporating children's toxicokinetics into a risk frameworkGary Ginsberg, William Slikker, James Bruckner, et al.
Trends in Pharmacological Sciences|July 28, 2016
Potential Reuse of Oncology Drugs in the Treatment of Rare DiseasesZhichao Liu, Hong Fang, William Slikker, et al.
Annals of the New York Academy of Sciences|July 11, 2003
Neuroprotection or neurotoxicity: impact of discontinuous dose-response curves on risk assessmentWilliam Slikker, Helen Duhart, David Gaylor, et al.
Pageof 14

Showing results (11-20 of 138) with videos related to

Sort By:
Pageof 14
Risk Analysis : an Official Publication of the Society for Risk Analysis|January 22, 2005
Role of the standard deviation in the estimation of benchmark doses with continuous dataDavid W Gaylor, William Slikker
Toxicology and Applied Pharmacology|June 22, 2005
Biomarkers of adult and developmental neurotoxicityWilliam Slikker, John F Bowyer
Reproductive Toxicology (Elmsford, N.Y.)|February 3, 2005
Application of a systems biology approach to developmental neurotoxicologyWilliam Slikker, Zengjun Xu, Cheng Wang
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 26, 2004
N-ethyl-N-nitrosourea (ENU) increased brain mutations in prenatal and neonatal mice but not in the adultsWilliam Slikker, Nan Mei, Tao Chen
Annals of the New York Academy of Sciences|September 24, 2005
Systems biology/systems toxicology: application to developmental neurotoxicology/neuroprotectionWilliam Slikker, Zengjun Xu, Cheng Wang
Journal of the American Association for Laboratory Animal Science : JAALAS|November 13, 2007
Effect of prolonged ketamine exposure on cardiovascular physiology in pregnant and infant rhesus monkeys (Macaca mulatta)Charlotte E Hotchkiss, Cheng Wang, William Slikker
Experimental Biology and Medicine (Maywood, N.J.)|June 16, 2023
Preface: 2022 International Conference on Neuroprotective AgentsWilliam Slikker, Tucker A Patterson, Russell J Andrews
Environmental Health Perspectives|February 3, 2004
Incorporating children's toxicokinetics into a risk frameworkGary Ginsberg, William Slikker, James Bruckner, et al.
Trends in Pharmacological Sciences|July 28, 2016
Potential Reuse of Oncology Drugs in the Treatment of Rare DiseasesZhichao Liu, Hong Fang, William Slikker, et al.
Annals of the New York Academy of Sciences|July 11, 2003
Neuroprotection or neurotoxicity: impact of discontinuous dose-response curves on risk assessmentWilliam Slikker, Helen Duhart, David Gaylor, et al.
Pageof 14